Risk factors for acute retinopathy of prematurity

Comprehensive Therapy

Volumn 33, Issue 2, 2007, Pages 73-77

  Al Amro, Saleh A ^a   Al Kharfi, Turki M ^b   Thabit, Abdulla A ^a   Al Mofada, Saleh M ^b  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DEXAMETHASONE; INDOMETACIN; STEROID;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; BRAIN HEMORRHAGE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; GESTATIONAL AGE; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MORBIDITY; PREMATURITY; RETROLENTAL FIBROPLASIA; RISK FACTOR;

BIRTH WEIGHT; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; REGRESSION ANALYSIS; RETINOPATHY OF PREMATURITY; RISK FACTORS; SAUDI ARABIA;

EID: 36949018192     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12019-007-8008-5     Document Type: Article

References (36)

1. McNamara JA, Moreno R, Tasman WS. Retinopathy of prematurity. In: Tasman W, Jaeger EA, editors. Duane's clinical ophthalmology. Volume 3. Philadelphia: Lippincott-Raven; 1996.
2. Pierce EA, Petersen RA, Smith LE. Retinopathy of prematurity. In: Albert DM, Jakoiec MD, editors. Principles and practice of ophthalmology. Philadelphia: W.H. Saunders; 2000. p. 4443-60.
3. Phleps DL. Vitamin E and retrolental fibroplasias in 1982. Pediatrics 1982;70:420-4.
4. Al-Amro SA, Al-Kharfi TM, Thabit AA, et al. Retinopathy of prematurity at King Khaled University Hospital in Riyadh. Saudi Med J 2003;24:720-4.
5. Hunter DG, Mukai S. Retinopathy of prematurity: pathogenesis, diagnosis and treatment. Int Ophthalmol Clin 1992;32:163-84.
6. Compbell PB, Bull MJ, Ellis FD. Incidence of retinopathy of prematurity in a tertiary newborn Intensive Care unit. Arch Ophthalmol 1983;101:1686-8.
7. Quinn GE, Johnson L, Abbasi S. Onset of retinopathy of prematurity as related to post natal and postconceptional age. Br J Ophthalmol 1992;76:284-8.
8. Kinsey VE, Jacobus JT, Hemphill FM. Cooperative study of retrolental fibroplasia and the use of oxygen. Arch Ophthalmol 1956;56:481-529.
9. Flyn JT, Bancalari E, Snyder SE. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med 1992;326:1050-4.
10. Lucey JF, Dangman B. A reexamination of the role of oxygen in retrolental fibroplasias. Pediatrics 1984;73:82-96.
11. Owens WC, Owens EU. Retrolental fibroplasia in premature infants: II. Studies on the prophylaxis of the disease: the use of alphatocopheryl acetate. Am J Ophthalmol 1949;32:497-505.
12. Hittner HM, Godio LB, Rudolph AJ. Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants. N Engl J Med 1981;305:1365-71.
13. Finer NN, Grant G, Schindler RF. Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia: a controlled trial. Lancet 1982;1:1087-91.
14. Johnson L, Quinn GE, Abbasi S, et al. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial. J Pediatr 1989;114:827-38.
15. Puklin JE, Simon RM, Ehrenkranz RA. Influence on retrolental fibroplasia of intramuscular vitamin E administration during respiratory distress syndrome. Ophthalmology 1982;89:96-102.
16. Milner RA, Bell E, Blanchette V. Vitamin E supplement in under 1500 gram neonates. Retinopathy of prematurity conference, December 4-6, 1981. Columbus: Ross Laboratories; 1981. p. 703-16.
17. Phelps DL, Rosenbaum AL, Isenberg SJ. Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial. Pediatrics 1987;79:489-500.
18. Committee of the Institute of Medicine. A report of a study-vitamin E and retinopathy of prematurity. IOM-86-02. Washington, DC: National Academy Press; 1986.
19. Ehrenkranz RA. Vitamin E and retinopathy of prematurity: still controversial. J Pediatr 1989;114:801-3.
20. Brown DR, Biglan AW, Stretavsky MM. Retinopathy of prematurity: the relationship with intraventricular hemorrhage and bronchopulmonary dysplasia. J Pediatr Ophthalmol Strabismus 1990;27:268-71.
21. Bassiouny MR. Risk factors associated with retinopathy of prematurity: a study from Oman. J Trop Pediatr 1996;42:355-8.
22. Arroe M, Peitersen B. Retinopathy of prematurity: review of a seven-year period in a Danish neonatal intensive care unit. Acta Paediatr 1994;83:501-5.
23. Batton DG, Roberts C, Trese M. Severe retinopathy of prematurity and steroid exposure. Pediatrics 1992;90:534-6.
24. Flower RW, Blake DA, Wajer SD. Retrolental fibroplasia: evidence for a role of the prostaglandin cascade in the pathogenesis of oxygen-induced retinopathy in the newborn beagle. Pediatr Res 1981;15:1293-302.
25. Schmidt B, Davis P, Moddemann D. Long-term effects of indomethacin prophylaxis in extremely low birth weight infants. N Engl J Med 2001;28:1966-72.
26. Bandstra ES, Montalvo BM, Goldberg RN. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics 1988;82:533-42.
27. Yeh TF, Raval D, Pyati S, et al. Retinopathy of prematurity and indomethacin therapy in premature infants with patent ductus arteriosus. Prostaglandins 1983;25:385-91.
28. Darlow BA, Horwood LJ, Clement ERS. Retinopathy of prematurity: risk factors in a prospective population-based study. Paediatr Perinat Epidemiol 1992;6:62-80.
29. Nandgaonkar BN, Rotschild T, Yu K, Higgins RD. Indomethacin improves oxygen-induced retinopathy in the mouse. Pediatr Res 1999;46:184-8.
30. Beauchamp MH, Martinez-Bermudez AK, Gobeil F Jr, et al. Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy. J Appl Physiol 2001;90:2279-88.
31. Stuart MJ, Phelps DL, Setty BN. Changes in oxygen tension and effects on cyclooxygenase metabolites: III. Decrease of retinal prostacyclin in kittens exposed to hyperoxia. Pediatrics 1999;82:367-72.
32. Harold J, Schmidt B. Evidence-based neonatology; making a difference beyond discharge from the neonatal nursery. Curr Opin Pediatr 2002;14:165-9.
33. Knight DB. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 2001;6:63-73.
34. Rowlands E, Ionides AC, Chinn S, et al. Reduced incidence of retinopathy of prematurity. Br J Ophthalmol 2001;85:933-5.
35. Console V, Gagliardi L, De Giorgi A, et al. Retinopathy of prematurity and antenatal corticosteroids. The Italian ROP Study Group. Acta Biomed Ateneo Parmense 1997;68 Suppl 1:75-9.
36. Blair BM, O'Halloran HS, Pauly TH, Stevens JL. Decreased incidence of retinopathy of prematurity 1995-1997. J AAPOS 2001;5:118-22.